Latest Financials News

Page 96 of 1447
London City Equities Limited reported a 38% revenue increase and a $5.6 million capital gain from asset sales, while boosting liquidity to nearly 60% of its portfolio and raising dividends amid a cautious investment outlook.
Claire Turing
Claire Turing
20 Feb 2026
Multistack International Limited posted a surprising $2.26 million net profit for 2025, driven by one-off settlement income, while its core operations continue to falter, prompting plans to exit its current business model.
Victor Sage
Victor Sage
20 Feb 2026
WA Kaolin reported $2.7 million in sales for the December quarter, secured a $1.5 million working capital loan, and restructured $20.4 million of debt, while focusing on plant improvements and cost reductions to address negative margins.
Maxwell Dee
Maxwell Dee
20 Feb 2026
BSA Limited reported an 84% plunge in revenue for the half-year ending December 2025, driven by lost contracts and reduced volumes, yet managed a $6.3 million profit amid restructuring and cost controls. Significant board changes signal a strategic reset as the company navigates uncertain waters.
Victor Sage
Victor Sage
20 Feb 2026
Advanced Innergy Holdings Ltd (ASX:AIH) has reported a robust FY25 performance highlighted by a successful IPO and strong growth across its core segments, setting a confident tone for FY26.
Victor Sage
Victor Sage
20 Feb 2026
FortifAI Limited has raised $5 million through a strategic placement led by a major Australian institutional fund manager, reinforcing its balance sheet and accelerating its AI development and commercialisation plans.
Sophie Babbage
Sophie Babbage
20 Feb 2026
Rural Funds Group has reported a striking 292% surge in profit after tax for the half year ending December 2025, alongside a 13% rise in revenue, signalling robust growth in its agricultural property portfolio.
Victor Sage
Victor Sage
20 Feb 2026
SRJ Technologies has secured multiple new purchase orders for its BoltEx flange clamp technology from major international operators, reinforcing its growing global footprint and industry validation.
Maxwell Dee
Maxwell Dee
20 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
GR Engineering Services reports a solid half-year performance with $218 million revenue and a raised interim dividend, underscoring confidence amid softer top-line results.
Victor Sage
Victor Sage
20 Feb 2026
Identitii Limited has reopened its pro rata rights issue following a Takeovers Panel ruling, granting shareholders withdrawal rights and terminating the underwriting agreement.
Sophie Babbage
Sophie Babbage
20 Feb 2026
Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.
Victor Sage
Victor Sage
20 Feb 2026